Granulocyte colony‐stimulating factor (G‐CSF) was significantly higher in AD mice treated with this approach, and this factor has been shown to reduce and even reverse cognitive deficits in Aβ deposition in AD mouse models (Figure 3).60 This evidence concerns the gene CSF3 and Alzheimer disease.